Page 24 - MI-2-1

Microbes & Immunity Sepsis and gut microbiome

100. Ware LB, Magarik JA, Wickersham N, et al. Low plasma Kyn/AHR axis. Gut. 2023;72(12):2272-2285.
citrulline levels are associated with acute respiratory doi: 10.1136/gutjnl-2023-329543
distress syndrome in patients with severe sepsis. Crit Care.
2013;17(1):R10. 106. Li D, Wei R, Zhang X, et al. Gut commensal metabolite
rhamnose promotes macrophages phagocytosis by activating
doi: 10.1186/cc11934 SLC12A4 and protects against sepsis in mice. Acta Pharm
101. Shen LJ, Guan YY, Wu XP, et al. Serum citrulline as a Sin B. 2024;14(7):3068-3085.
diagnostic marker of sepsis-induced intestinal dysfunction. doi: 10.1016/j.apsb.2024.03.025
Clin Res Hepatol Gastroenterol. 2015;39(2):230-236.
107. Chen Y, Sun K, Qi Y, Tang J, Zhu H, Wang Z. L-valine
doi: 10.1016/j.clinre.2014.10.002 derived from the gut microbiota protects sepsis-induced
102. Jaiswal VK, Kabaciński P, Nogueira De Faria BE, et al. intestinal injury and negatively correlates with the severity
Environment-driven coherent population transfer governs of sepsis. Front Immunol. 2024;15:1424332.
the ultrafast photophysics of tryptophan. J Am Chem Soc. doi: 10.3389/fimmu.2024.1424332
2022;144(28):12884-12892.
108. Li J, Chen Y, Li R, et al. Gut microbial metabolite
doi: 10.1021/jacs.2c04565 hyodeoxycholic acid targets the TLR4/MD2 complex to
103. Xia L, Hantrakun V, Teparrukkul P, et al. Plasma attenuate inflammation and protect against sepsis. Mol Ther.
metabolomics reveals distinct biological and diagnostic 2023;31(4):1017-1032.
signatures for melioidosis. Am J Respir Crit Care Med. doi: 10.1016/j.ymthe.2023.01.018
2024;209(3):288-298.
109. Kim SM, DeFazio JR, Hyoju SK, et al. Fecal microbiota
doi: 10.1164/rccm.202207-1349OC transplant rescues mice from human pathogen mediated
104. Fang H, Fang M, Wang Y, et al. Indole-3-propionic acid as a sepsis by restoring systemic immunity. Nat Commun.
potential therapeutic agent for sepsis-induced gut microbiota 2020;11(1):2354.
disturbance. Microbiol Spectr. 2022;10(3):e0012522. doi: 10.1038/s41467-020-15545-w
doi: 10.1128/spectrum.00125-22 110. DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-resistant E.
coli bacteremia transmitted by fecal microbiota transplant.
105. Fong W, Li Q, Ji F, et al. Lactobacillus gallinarum-derived
metabolites boost anti-PD1 efficacy in colorectal cancer by N Engl J Med. 2019;381(21):2043-2050.
inhibiting regulatory T cells through modulating IDO1/ doi: 10.1056/NEJMoa1910437

Volume 2 Issue 1 (2025) 16 doi: 10.36922/mi.4742